Gastroenterology

This systematic review synthesizes evidence on microbiome-targeted therapies for irritable bowel syndrome, including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation.

This prospective cohort study of 172,456 UK Biobank participants examines the association between long-term proton pump inhibitor use and the risk of incident chronic kidney disease over a median follow-up of 12.4 years.